Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
SALES / VALUECompleted eBay sales; useful support, especially for the global market.
Transaction-based price; use it as the valuation baseline.
Transaction-based price; use it as the valuation baseline.
Seller asking prices. They show availability but do not prove demand.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-11-07 | TCG | $14.74 | — |
| 2026-11-06 | List | €20.00 | -4.3% |
| 2026-11-06 | Sold | €11.63 | -3.6% |
| 2026-11-06 | TCG | $14.74 | -0.2% |
| 2026-11-05 | Sold | €12.07 | -1.5% |
| 2026-11-05 | TCG | $14.77 | -0.1% |
| 2026-11-05 | EB | $15.99 | +0.3% |
| 2026-11-04 | List | €20.89 | +4.5% |
| 2026-11-04 | Sold | €12.25 | -0.3% |
| 2026-11-04 | TCG | $14.78 | -1.4% |
| 2026-11-04 | EB | $15.94 | -4.7% |
| 2026-11-03 | Sold | €12.29 | — |
| 2026-11-03 | TCG | $14.99 | -2.5% |
| 2026-11-03 | EB | $16.73 | +5.3% |
ME: Ascended Heroes / #238/217/Holofoil
Germany: lowest · Spain: below average · EU average €19.13Choose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
NMRAW | $14.74 | $14.74 | $14.74 | -15.0% | >5 | |
AggregatedRAW | €11.63 | €4.95 | €49.31 | -15.0% | >5 | |
LPRAW | $11.74 | $11.74 | $11.74 | -15.0% | >5 | |
DMGRAW | $4.59 | $4.59 | $4.59 | -15.0% | >5 | |
MPRAW | $17.78 | $17.78 | $17.78 | -15.0% | >5 | |
MINTRAW | €11.63 | €4.95 | €49.31 | -15.0% | >5 | |
HEAVILY PLAYEDRAW | $20.00 | $20.00 | $20.00 | -15.0% | >5 |
Explore Team Rocket's Mimikyu #238/217, Holofoil from ME: Ascended Heroes, with 1572 price records for the US market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.